Search Browse Earnings

Indaptus Therapeutics, Inc. — SlamSEC

Indaptus Therapeutics, Inc.

Nasdaq:INDP

Pharmaceutical Preparations·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$16.4M

FY 2024

Net Income

-$15.4M

FY 2024

EPS (Diluted)

-$1.83

FY 2024

Stock Price

$1.74

-6.5%

2026-03-09

52W Range

$1.52 – $47.60

P/E Ratio

-1.0x

Market Cap

$3.0M

Cash

$13.4M

FY 2024

Total Debt

—

Net Cash

$13.4M

Enterprise Value

-$10.3M

Debt / EBITDA

0.8x

FY 2024

EV / EBITDA

0.6x

Employees

—

CEO

Meckler Jeffrey A

CFO

Sassi Nir